|
Volumn 127, Issue 29, 2005, Pages 10130-10131
|
Structure-based design of potent non-peptide MDM2 inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALSTONISINE;
ANTINEOPLASTIC AGENT;
PROTEIN INHIBITOR;
PROTEIN MDM2;
PROTEIN MDM2 INHIBITOR;
PROTEIN P53;
SPIROTRYPROSTATIN A;
UNCLASSIFIED DRUG;
ARTICLE;
BINDING AFFINITY;
CRYSTAL STRUCTURE;
DRUG DESIGN;
DRUG POTENCY;
FLUORESCENCE POLARIZATION;
HUMAN;
HUMAN CELL;
HYDROGEN BOND;
HYDROPHOBICITY;
IC 50;
MOLECULAR MODEL;
PROTEIN PROTEIN INTERACTION;
STEREOSPECIFICITY;
STRUCTURE ACTIVITY RELATION;
X RAY CRYSTALLOGRAPHY;
BIOMIMETIC MATERIALS;
CRYSTALLOGRAPHY, X-RAY;
DRUG DESIGN;
INDOLE ALKALOIDS;
MODELS, MOLECULAR;
NUCLEAR PROTEINS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MDM2;
SPIRO COMPOUNDS;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 22944473048
PISSN: 00027863
EISSN: None
Source Type: Journal
DOI: 10.1021/ja051147z Document Type: Article |
Times cited : (605)
|
References (9)
|